The Argentina MRI market is projected to grow at a CAGR of 2.63% to reach US$0.109 billion by 2024, from US$0.093 billion in 2018. The MRI market in Argentina is growing owing to the prevalence of the elderly population, and the prevalence of chronic diseases. Furthermore, growing health expenditure is augmenting the market growth during the forecast period. In addition, growing research activities will provide an opportunity for MRI installations for research and clinical purposes during t Read more...
The Middle East and Africa drug delivery market is projected to grow at a CAGR of 11.90% to reach US$ 40.744 billion by 2024, from US$ 22.128 billion in 2018. The drug delivery market in Middle East and Africa is poised to grow at a fast pace owing to the growing geriatric population, and the prevalence of chronic diseases. Furthermore, improvement in health systems is augmenting the market growth during the forecast period. This research study examines the current market trends rela Read more...
The South America drug delivery market is projected to grow at a CAGR of 11.60% to reach US$ 57.300 billion by 2024, from US$ 29.654 billion in 2018. The drug delivery market in South America is poised to grow at a rapid pace owing to the growing pharmaceutical market, an aging population, and the prevalence of chronic diseases. Furthermore, growing health expenditure is augmenting the market growth during the forecast period. This research study examines the current market trends re Read more...
The Oral drug delivery market is projected to grow at a CAGR of 6.99% to reach US$ 150.003 billion by 2024. Oral drug delivery is referred to the transfer of drug into the human body through an oral route of administration. This is considered as the most convenient route of administration and is preferred widely among a wide range of consumers. These are in high demand due to the prevalence of chronic diseases worldwide. Furthermore, rising R&D investment, growing health expenditure and a Read more...
The nasal drug delivery market is projected to grow at a CAGR of 6.58% to reach US$76.083 billion by 2024, from US$51.917billion in 2018. Nasal drug delivery is referred to the transfer of drug into the human body through an intranasal route of administration. These are in high demand owing to the convenience of administration in addition to providing improved patient compliance. Also, there are certain drugs which are not suitable for oral or parenteral administration, thus, calling for the Read more...
The injectable drug delivery market is projected to grow at a CAGR of 10.37% to reach US$ 804.844 billion by 2024. Injectable drug delivery is considered to be the most effective means of drug delivery into the human body and is thus considered to be the most effective administration route. These are in high demand due to the prevalence of chronic diseases worldwide driving the market growth during the forecast period. Furthermore, growing R&D activities, growing health expenditure and gr Read more...
The inhalation drug delivery market is expected to grow at a CAGR of 3.58% by the end of 2024. Inhalation drug delivery is referred to the transfer of drug into the human body through the lungs or it is also known as the pulmonary route of administration. These are available in either liquid or in powdered form. The market is poised to grow during the forecast period owing to the prevalence of asthma and COPD (Chronic Obstructive Pulmonary Disease). Furthermore, the growing geriatric populati Read more...
The USA Drug Delivery market is projected to grow at a CAGR of 8.33% to reach US$ 461.716 billion by 2024, from US$ 285.607 billion in 2018. The drug delivery market here is poised to grow during the forecast period as the pharmaceutical industry in the United States, one of the mainstays of America’s economy plays a crucial role in the global pharmaceutical industry. An aging population and the high prevalence of chronic diseases are further driving the market growth in the forecast period. Read more...
The Canada Drug Delivery market is projected to grow at a CAGR of 9.21% to reach US$ 25.061 billion by 2024, from US$ 14.770 billion in 2018. The drug delivery market here is poised to grow at a fast pace owing to the pharma sector being considered as one of the most innovative industries in Canada, a rapidly aging population and prevalence of chronic diseases. Furthermore, growing health expenditure is augmenting the market growth during the forecast period. In the end, growing research acti Read more...
The Mexico Drug Delivery market is projected to grow at a CAGR of 15.12% to reach US$ 14.215 billion by 2024, from US$ 6.107 billion in 2018. The drug delivery market in Mexico is poised to grow at a fast pace owing to the growing pharmaceutical industry here, an aging population and prevalence of chronic diseases. Furthermore, growing innovations in drug delivery will provide an opportunity for the growth of the Mexico drug delivery market in the forecast period and beyond. This resear Read more...
.jpg)
